Studies of Plasma Quinidine Content
- 1 April 1952
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 5 (4), 534-538
- https://doi.org/10.1161/01.cir.5.4.534
Abstract
Quinidine sulfate, orally administered in tablets coated with a material delaying their absorption, produces concentration curves in the blood serum similar to those of uncoated tablets. However, there is a delay in the appearance and the attaining of maximum concentrations with the coated tablets, although higher levels may persist for 12 hours. Defects in coating may cause faulty failure of absorption. The advantages of using such a preparation of quinidine are: (1) avoidance of nausea in susceptible persons, (2) providing effective concentrations of the drug during the night and thereby preventing nocturnal attacks of arrhythmias, and (3) providing greater concentrations of the drug in the morning, when attempts at conversions of arrhythmias may require therapy over several days or more.Keywords
This publication has 4 references indexed in Scilit:
- Studies of Plasma Quinidine ContentCirculation, 1950
- Studies of Plasma Quinidine ContentCirculation, 1950
- Correlation between the effect of quinidine sulfate on the heart and its concentration in the blood plasmaThe American Journal of Medicine, 1948
- Plasma concentrations of quinidine with particular reference to therapeutically effective levels in two cases of paroxysmal nodal tachycardiaAmerican Heart Journal, 1946